Education
About Us
Working with TipRanks
Follow Us
Veracyte (VCYT)
NASDAQ:VCYT
Total Valuation
Veracyte has a market cap or net worth of $2.26B. The enterprise value is $2.15B.
Market Cap$2.26B
Enterprise Value$2.15B
Share Statistics
Veracyte has 78,314,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding78,314,610
Owned by Insiders1.43%
Owned by Institutions1.58%
Financial Efficiency
Veracyte’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.19%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)1.19%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee540.98K
Profits Per Employee29.29K
Employee Count824
Asset Turnover0.34
Inventory Turnover6.79
Valuation Ratios
The current PE Ratio of Veracyte is 125.48. Veracyte’s PEG ratio is 2.00.
PE Ratio125.48
PS Ratio0.00
PB Ratio1.91
Price to Fair Value2.58
Price to FCF29.14
Price to Operating Cash Flow25.47
PEG Ratio2.00
Income Statement
In the last 12 months, Veracyte had revenue of 445.76M and earned 24.14M in profits. Earnings per share was 0.31.
Revenue445.76M
Gross Profit298.14M
Operating Income16.14M
Pretax Income25.74M
Net Income24.14M
EBITDA49.20M
Earnings Per Share (EPS)0.31
Cash Flow
In the last 12 months, operating cash flow was 89.42M and capital expenditures -10.97M, giving a free cash flow of 78.45M billion.
Operating Cash Flow89.42M
Free Cash Flow78.45M
Free Cash Flow per Share1.00
Dividends & Yields
Veracyte pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.63
52-Week Price Change27.71%
50-Day Moving Average30.66
200-Day Moving Average35.28
Relative Strength Index (RSI)36.50
Average Volume (3m)1.09M
Important Dates
Veracyte upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date―
Financial Position
Veracyte as a current ratio of 4.73, with Debt / Equity ratio of 4.23%
Current Ratio4.73
Quick Ratio4.46
Debt to Market Cap<0.01
Net Debt to EBITDA-3.83
Interest Coverage Ratio8.07K
Taxes
In the past 12 months, Veracyte has paid 1.61M in taxes.
Income Tax1.61M
Effective Tax Rate0.06
Enterprise Valuation
Veracyte EV to EBITDA ratio is 57.73, with an EV/FCF ratio of 44.51.
EV to Sales6.37
EV to EBITDA57.73
EV to Free Cash Flow44.51
EV to Operating Cash Flow37.82
Balance Sheet
Veracyte has $287.36M in cash and marketable securities with $50.50M in debt, giving a net cash position of -$236.85M billion.
Cash & Marketable Securities$287.36M
Total Debt$50.50M
Net Cash-$236.85M
Net Cash Per Share-$3.02
Tangible Book Value Per Share$4.29
Margins
Gross margin is 67.56%, with operating margin of 3.62%, and net profit margin of 5.41%.
Gross Margin67.56%
Operating Margin3.62%
Pretax Margin5.78%
Net Profit Margin5.41%
EBITDA Margin11.04%
EBIT Margin5.78%
Analyst Forecast
The average price target for Veracyte is $39.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$39.67
Price Target Upside43.68% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast23.42%
EPS Growth Forecast―